Trial Profile

A phase 1b single center, open label study of VLS-01 in healthy participants

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 19 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs N-N-dimethyltryptamine (Primary) ; N-N-dimethyltryptamine
Indications Depressive disorders
Focus Adverse reactions

Most Recent Events

13 Aug 2024 Preliminary Results Phase 1b Trial of VLS-01 assessing effect intensity and safety as well as tolerability presented in the Atai Life Sciences Media Release.
04 Mar 2024 According to an Atai Life Sciences, the first patient has been dosed in this trial. Top-line results for the Phase 1b study are expected in the second half of this year.
04 Mar 2024 Status changed from planning to recruiting, according to an Atai Life Sciences.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com